Skip To Main Content
Alexandra Strickler on Muck Rack

Alexandra Strickler

  • Health Writer and Editor, Labcorp
New York
As seen in: Labcorp, Elite Daily, InStyle, SHAPE
Health/Wellness Writer/Editor. Bylines @EliteDaily, @Shape_Magazine, @onedroptoday. Lover of all things writing, felines, the universe, and potatoes.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Alexandra

Contact Alexandra, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

This Nose-Only COVID Mask for Eating and Drinking Is Going Viral

|
By Alexandra Strickler
| SHAPE Verified
Researchers in Mexico created a “nose-only mask” to help reduce the spread of COVID while eating and drinking. Here’s what other experts think of the idea. By Allie Strickler March 31, 2021 It's no secret that going out to bars and restaurants is tied to an increased risk of COVID infection. While many places require you to arrive wearing a mask and put it back on to go to the bathroom, once you're at your table, you're typically allowed to keep your mask off to allow for eating and drinking.
Open in Who Shared Issue with article?

Everything You Need to Know About the Oxford AstraZeneca Vaccine

|
By Alexandra Strickler
| SHAPE Verified
Three COVID-19 vaccines are already authorized by the Food and Drug Administration (FDA) for emergency use in the U.S. — Pfizer, Moderna, and Johnson & Johnson — and a fourth may not be far behind. On March 22, AstraZeneca announced promising results of a U.S. clinical trial of more than 30,000 people.
Open in Who Shared Issue with article?

What Makes Johnson & Johnson's COVID Vaccine Different from the Others?

|
By Alexandra Strickler
| SHAPE Verified
On February 4, Johnson & Johnson announced its application to the FDA for emergency use authorization (EUA) of its COVID-19 vaccine. Come February 26, the FDA’s vaccine advisory committee will meet to discuss the vaccine and vote on whether it should be authorized. If Johnson & Johnson gets the green light, that means the vaccine could be ready for use in the U.S. by the end of March, according to the Center for Infectious Disease Research and Policy (CIDRAP).
Open in Who Shared View Duplicates (4) Issue with article?
See all 407 articles